Massimo Libra

Active 2002–2025

139
Papers
19,690
Citations
80
h-index
133
i10-index

Citations

Citations per year for Massimo Libra1992: 1 citations2001: 1 citations2003: 5 citations2004: 1 citations2005: 2 citations2006: 16 citations2007: 18 citations2008: 50 citations2009: 79 citations2010: 101 citations2011: 139 citations2012: 150 citations2013: 143 citations2014: 152 citations2015: 146 citations2016: 143 citations2017: 169 citations2018: 146 citations2019: 768 citations2020: 1,076 citations2021: 1,154 citations2022: 794 citations2023: 526 citations2024: 798 citations2025: 373 citations2026: 12 citations1993–2000: no citations, so these years are not shown2002: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,532 citing papers, 17.3% of this breakdownChina: 1,425 citing papers, 16.1% of this breakdownItaly: 697 citing papers, 7.9% of this breakdownIndia: 414 citing papers, 4.7% of this breakdownUnited Kingdom: 301 citing papers, 3.4% of this breakdownGermany: 293 citing papers, 3.3% of this breakdownIran: 229 citing papers, 2.6% of this breakdownSpain: 209 citing papers, 2.4% of this breakdownFrance: 207 citing papers, 2.3% of this breakdownSouth Korea: 203 citing papers, 2.3% of this breakdownCanada: 173 citing papers, 1.9% of this breakdownAustralia: 167 citing papers, 1.9% of this breakdown
0%17.3%Other 33.9%

Fields

  • Biochemistry, Genetics and Molecular Biology42.3%
  • Medicine41.3%
  • Immunology and Microbiology4%
  • Agricultural and Biological Sciences1.9%
  • Neuroscience1.7%
  • Computer Science1.6%
  • Other7.2%

Topics

  • PI3K/AKT/mTOR signaling in cancer2.7%
  • MicroRNA in disease regulation2.2%
  • Melanoma and MAPK Pathways2%
  • Gut microbiota and health1.8%
  • Cancer-related molecular mechanisms research1.7%
  • Cancer Immunotherapy and Biomarkers1.6%
  • Other88%

Coauthors

All papers

Open in search
  1. Roles of the Raf/MEK/ERK pathway in cell growth, malignant transformation and drug resistance

    Authors: , , , , , , , , , , , , , , , - Biochimica et Biophysica Acta (BBA) - Molecular Cell Research 2006 cited by 2,288

  2. Evolution of Cancer Pharmacological Treatments at the Turn of the Third Millennium

    Authors: , , - Frontiers in Pharmacology 2018 cited by 887

  3. Gut Microbiota and Cancer: From Pathogenesis to Therapy

    Authors: , , , , , , , , , - Cancers 2019 cited by 578

  4. Cutaneous melanoma: From pathogenesis to therapy (Review)

    Authors: , , , , , , , - International Journal of Oncology 2018 cited by 592

  5. Roles of the Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR pathways in controlling growth and sensitivity to therapy-implications for cancer and aging

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , - Aging 2011 cited by 700

  6. Targeting GSK3 and Associated Signaling Pathways Involved in Cancer

    Authors: , , , , , , , , , , , , , - Cells 2020 cited by 272

  7. The Effect of Dietary Polyphenols on Vascular Health and Hypertension: Current Evidence and Mechanisms of Action

    Authors: , , , , , , , , , , , - Nutrients 2022 cited by 149

  8. Akt inhibitors in cancer treatment: The long journey from drug discovery to clinical use (Review)

    Authors: , , , , , , , , , - International Journal of Oncology 2015 cited by 364

  9. GSK-3 as potential target for therapeutic intervention in cancer

    Authors: , , , , , , , , , , , , , , , , , - Oncotarget 2014 cited by 505

  10. Current and Future Trends on Diagnosis and Prognosis of Glioblastoma: From Molecular Biology to Proteomics

    Authors: , , , , , , , , , - Cells 2019 cited by 231

  11. Effects of resveratrol, curcumin, berberine and other nutraceuticals on aging, cancer development, cancer stem cells and microRNAs

    Authors: , , , , , , , , , , , , , , , , , , , , , - Aging 2017 cited by 281

  12. Ageing: from inflammation to cancer

    Authors: , , , , - Immunity & Ageing 2018 cited by 235

  13. Current Perspectives in Cancer Immunotherapy

    Authors: , , , , - Cancers 2019 cited by 211

  14. Lactobacillus rhamnosus GG cell-free supernatant as a novel anti-cancer adjuvant

    Authors: , , , , , , , - Journal of Translational Medicine 2023 cited by 55

  15. Lactobacillus rhamnosus GG: An Overview to Explore the Rationale of Its Use in Cancer

    Authors: , , , , , , , , - Frontiers in Pharmacology 2017 cited by 147

  16. Mutations and Deregulation of Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR Cascades Which Alter Therapy Response.

    Authors: , , , , , , , , , , , , , , , , , , , , - Oncotarget 2012 cited by 305

  17. Multifaceted roles of GSK-3 and Wnt/β-catenin in hematopoiesis and leukemogenesis: opportunities for therapeutic intervention

    Authors: , , , , , , , , , , , , , - Leukemia 2013 cited by 252

  18. Cancer-associated stroke: Pathophysiology, detection and management (Review)

    Authors: , , , , , , , , , , , , , , - International Journal of Oncology 2019 cited by 274

  19. Functional Roles of Matrix Metalloproteinases and Their Inhibitors in Melanoma

    Authors: , , , , , , , - Cells 2020 cited by 142

  20. Roles of the RAF/MEK/ERK and PI3K/PTEN/AKT pathways in malignant transformation and drug resistance

    Authors: , , , , , , , , , , , , , - Advances in Enzyme Regulation 2006 cited by 663

  21. Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR Inhibitors: Rationale and Importance to Inhibiting These Pathways in Human Health

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , - Oncotarget 2011 cited by 576

  22. The therapeutic potential of mTOR inhibitors in breast cancer

    Authors: , , , , , , - British Journal of Clinical Pharmacology 2016 cited by 124

  23. Quality of Life in Women Diagnosed with Breast Cancer after a 12-Month Treatment of Lifestyle Modifications

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Samuele Massarut, Laura Caggiari, Chiara Evangelista, Agostino Steffan, Francesca Catalano, Giuseppe Luigi Banna, Giuseppa Scandurra, Francesco Ferraù, Rosalba Rossello, Giovanna Antonelli, Gennaro Guerra, Amalia Farina, Francesco Messina, Gabriele Riccardi, Davide Gatti, David J.A. Jenkins, Egidio Celentano, Gerardo Botti, Livia S. A. Augustin - Nutrients 2020 cited by 110

  24. SnapShot: Cancer chemotherapy

    Authors: , , - Cell 2023 cited by 60